Tokyo, May 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061435) titled 'Real-World Use of Diabetes Technology and Associated Clinical Outcomes in People With Type 1 Diabetes: The Kyoto T1D-TECH Registry' on May 1.
Study Type:
Observational
Primary Sponsor:
Institute - National Hospital Organization Kyoto Medical Center
Condition:
Condition - Type 1 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The primary objective of this study was to clarify the real-world use of diabetes technologies in individuals with type 1 diabetes, including continuous glucose monitoring (CGM), continuous subcutaneous insulin infusion (CSII), and automated insulin delivery (AID) systems, and to examine their associations with glycemic metrics such as glycated hemoglobin (HbA1c) and time in range (TIR), as well as clinical outcomes.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 4
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Age 4 years or older
Diagnosis of type 1 diabetes mellitus (T1DM)
Key exclusion criteria - Age < 4 years
Participants considered unsuitable for participation in this study by the principal investigator or sub-investigators
Target Size - 300
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 20 Day
Anticipated trial start date - 2026 Year 04 Month 25 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069974
Disclaimer: Curated by HT Syndication.
